Date
June 22, 2021 - 9:00amEvent Description
Presenter: Dr. Katherine Hrebinko (advisor: Drs. Courcoulas and Myers)
Katherine will discuss early stage work and future plans for a cost-effectiveness analysis of metabolic surgery versus optimal medical/lifestyle therapy based on data from the Alliance of Randomized Trials of Medicine vs. Metabolic Surgery for Type II Diabetes (ARMMS-T2D), for which Dr. Courcoulas is one of the lead investigators. She will next present the results of a cost-effectiveness analysis of axillary observation versus sentinel lymph node biopsy in women > 70 with early-stage, hormone receptor-positive breast cancer that she completed under the direction of Drs. Myers, Diego, Downs-Canner, and Bryce.
Location and Address
MS Teams virtual meeting
Meeting logon info has been emailed to Department of Surgery staff. For Pitt and UPMC staff outside the department who wish to access the lecture, please email surgerywebmaster@upmc.edu.